Regenerating the Natural Beauty with Pure Science
Established in 1946, Fidia is an Italian multinational and one of the leading global players in the manufacture of hyaluronic acid-based products. We produce pharmaceutical-grade hyaluronic acid, in a wide range of molecular weights and with peculiar chemical-physical characteristics, depending on the indications and the desired properties of finished product.
Fidia’s approach in developing the Hyal System Line lies in the Weight – Concentration – Technology (W.C.T.) Concept, that is the unique combination of these three variables exploiting different structural and biological properties of HA and enabling each Hyal System Line product to bring out different targeted benefits.
Hyal System ACP is a low molecular weight HA-based gel, stabilized without involving any chemical agent, thanks to the patented ACP (Auto-Crosslinked Polymer) technology, to enable a gradual release of highly pure 200kDa HA.
Hyal System DUO is a new generation, bio-soft filler that combines 75% BDDE crosslinked HMW-HA and 25% auto crosslinked (ACP) LMW-HA.
Our expert panel will share latest findings on LMW-HA and their clinical experiences with Hyal System line.
is Rejuvenation Biorevitalization Redensification Filling Correction Volume
The WCT concept: Weight, Concentration, Technology
Nearly all effects of hyaluronan observed in vitro and in vivo systems depend on its molecular weight and its concentration.
Fidia’s approach in developing the Hyal System Line lies in the Weight – Concentration – Technology (WCT) Concept, that is the unique combination of these three variables exploit different structural and biological properties of HA, enabling each Hyal System Line product to bring out different targeted benefits.
is Regenerative Care Tissue Reconstruction Growth Factors
BEAUTY STEMS FROM WITHIN
From the regenerating power of hyaluronic acid to the future of medicine
After decades of research into hyaluronic acid, which is known for its benefits in the natural repair and regeneration processes of damaged tissues, today we are also progressing in the field of regenerative medicine.
